Zhejiang Hisun Pharmaceutical Co Ltd

600267

Company Profile

  • Business description

    Zhejiang Hisun Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is focused on the research, development, and distribution of pharmaceuticals. It produces and supplies antibiotics and anticancer drugs. The company's research channels cover indications like anticancer, cardiovascular, anti-infective, anti-parasitic, immunosuppressant and others. Its product portfolio includes active pharmaceutical ingredients like Anastrozole, Docetaxel, Methotrexate, and others and finished dosages such as letrozole tablets, anastrozole tablets, injection mitomycin, and others.

  • Contact

    No. 46 Waisha Road
    Jiaojiang District
    Zhejiang Province
    Taizhou318000
    CHN

    T: +86 4001180618

    http://www.hisunpharm.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    7,994

Stocks News & Analysis

stocks

Ask the analyst: How reliant are Guzman shares on international growth?

A year on from Guzman’s IPO, I catch up with Johannes Faul to explore what is baked into GYG’s valuation.
stocks

Nvidia: Back in business in China; Raising fair value estimate

Nvidia is poised to become more dominant than ever as it is allowed to sell its key H20 GPUs in China.
stocks

Our top ASX picks in every sector

These companies are our top choices for investors wanting to boost Aussie exposure.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,816.4058.90-0.66%
CAC 407,722.0944.12-0.57%
DAX 4024,009.3850.91-0.21%
Dow JONES (US)44,245.26221.970.50%
FTSE 1008,926.5511.77-0.13%
HKSE24,517.7672.36-0.29%
NASDAQ20,737.0559.250.29%
Nikkei 22539,663.4014.62-0.04%
NZX 50 Index12,754.5964.960.51%
S&P 5006,265.1721.410.34%
S&P/ASX 2008,561.8068.50-0.79%
SSE Composite Index3,503.781.22-0.03%

Market Movers